The long-term efficacy and tolerability of hyaluronic acid in adult patients with Kashin–Beck disease of the knee

Clinical Rheumatology

Volumn 34, Issue 1, 2015, Pages 151-156

  Tang, Xin ^a   Zhou, Zong Ke ^a   Liu, Gang ^a   Shen, Bin ^a   Kang, Peng De ^a   Li, Jian ^a   Li, Qi ^a   Pei, Fu Xing ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Efficacy; Hyaluronic acid; Kashin Beck disease; Knee

Indexed keywords

HYALURONIC ACID;

ADULT; ARTHRALGIA; ARTICLE; CLINICAL ASSESSMENT; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; INJECTION SITE BLEEDING; INJECTION SITE PAIN; INJECTION SITE SWELLING; JOINT EFFUSION; KASHIN BECK DISEASE; KNEE PAIN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PILOT STUDY; PRIORITY JOURNAL; VISUAL ANALOG SCALE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX; AGED; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; INTRAARTICULAR DRUG ADMINISTRATION; KASHIN-BECK DISEASE; KNEE; MIDDLE AGED; PAIN MEASUREMENT; PATHOLOGY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; KASHIN-BECK DISEASE; KNEE JOINT; MALE; MIDDLE AGED; PAIN MEASUREMENT; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84940733324     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2519-0     Document Type: Article

References (25)

1. Sokoloff L (1989) The history of Kashin–Beck disease. N Y State J Med 89:343–351
2. Chinese Health Statistical Digest (2010) http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjty/digest2010/index.html
3. Schepman K, Engelbert RH, Visser MM, Yu C, de Vos R (2011) Kashin Beck disease: more than just osteoarthrosis: a cross-sectional study regarding the influence of body function-structures and activities on level of participation. Int Orthop 35:767–776
4. Guo X (2001) Diagnostic, clinical and radiological characteristics of Kashin Beck disease in Shaanxi Province, PR China. Int Orthop 25:147–150
5. Li Y, Zhou Z, Shen B, Yang J, Kang P, Yang X et al (2013) Clinical features of Kashin–Beck disease in adults younger than 50 years of age during a low incidence period: severe elbow and knee lesions. Int Orthop 32:317–324
6. Zhou Z, Shen B, Pei F, Kang P, Li J, Yang J et al (2009) Relation between affected big joints and classification of Kashin–Beck disease in adult of Tibet. Chin J Bone Joint Surg 2:352–356
7. Cao J, Li S, Shi Z, Yue Y, Sun J, Chen J et al (2008) Articular cartilage metabolism in patients with Kashin–Beck disease: an endemic osteoarthropathy in China. Osteoarthr Cartil 16:680–688
8. Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE (2011) Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis—meta-analysis. Osteoarthr Cartil 19:611–619
9. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM (2004) Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86-A:538–545
10. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 19, CD005321
11. Xu P, Guo X, Jin W, Yao J, Wang J, Zhang F et al (2004) Curative effects of intra-articular injections of sodium hyaluronate to treat Kashin–Beck disease. Chin J Endemiol 23:588–590
12. Tang X, Pei FX, Zhou ZK, Liu G, Shen B, Kang PD et al (2012) A randomized, single-blind comparison of the efficacy and tolerability of hyaluronate acid and meloxicam in adult patients with Kashin–Beck disease of the knee. Clin Rheumatol 31:1079–1086
13. Li F, Deng J, Zhou D, Yang R, Li D, Ma G et al (2005) Analysis on monitoring data of Kashin–Beck disease in Sichuan Province in 2005. J Prev Med Inf 21:666–668
14. Mathieu F, Begaux F, Lan ZY, Suetens C, Hinsenkamp M (1997) Clinical manifestations of Kashin–Beck disease in Nyemo Valley, Tibet. Int Orthop 21:151–156
15. Kellgren JH, Lawrence JS (1957) Radiographic assessment of osteoarthritis. Ann Rheum Dis 16:494–502
16. Bellamy N (1995) WOMAC osteoarthritis index—a user’s guide. Canada, London Health Sciences Centre, London
17. Bellamy N (2002) WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire. J Rheumatol 29:2473–2476
18. Theiler R, Brühlmann P (2005) Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Curr Med Res Opin 21:1727–1733
19. Conrozier T, Mathieu P, Schott AM, Laurent I, Hajri T, Crozes P et al (2003) Factors predicting long-term efficacy of Hylan GF-20 viscosupplementation in knee osteoarthritis. Joint Bone Spine 70:128–133
20. Jüni P, Reichenbach S, Trelle S, Tschannen B, Wandel S, Jordi B et al (2007) Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis Rheum 56:3610–3619
21. Hamburger MI, Lakhanpal S, Mooar PA, Oster D (2003) Intra-articular hyaluronans: a review of product-specific safety profiles. Semin Arthritis Rheum 32:296–309
22. Reichenbach S, Blank S, Rutjes AW, Shang A, King EA (2007) Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthritis Rheum 57:1410–1418
23. Pagnano M, Westrich G (2005) Successful nonoperative management of chronic osteoarthritis pain of the knee: safety and efficacy of retreatment with intra-articular hyaluronans. Osteoarthr Cartil 13:751–761
24. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M (2008) The placebo effect and its determinants in osteoarthritis: metaanalysis of randomized controlled trials. Ann Rheum Dis 67:1716–1723
25. Juni P, Altman DG, Egger M (2001) Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323:42–46